Interpretation of Expert Consensus on Traditional Chinese Medicine Diagnosis and Treatment of Chronic Gastritis(2023)
-
摘要: 慢性胃炎是临床常见病、高发病，近年来在多因素致病、幽门螺杆菌(Hp)感染及根除治疗的影响、内镜下病变的人工智能识别、中医病机认识、内镜局部辨证、中药复方疗效评价、高风险人群监测等方面不断取得进步。2023年12月，由中华中医药学会脾胃病分会制订的《慢性胃炎中医诊疗专家共识(2023)》于《中华中医药杂志》发表，该共识在2017版共识意见的基础上对慢性胃炎的中西医诊治进展进行了更新与完善，为临床医师规范诊治慢性胃炎提供了更新、更全面的指导。本文对该共识进行解读，以期加深理解，提高慢性胃炎的临床诊治水平。Abstract: Chronic gastritis is a common and high-incidence clinical disease. In recent years, progress has been continuously made in the pathogenesis of multifactorial causes, the effect of Helicobacter pylori(Hp) infection and its treatment on lesions, artificial intelligence identification of endoscopic lesions, traditional Chinese medicine recognition of pathogenesis, syndrome differentiation based on endoscopic findings, efficacy evaluation of Chinese medicine compound prescriptions, and monitoring of high-risk populations. In December 2023, the "Expert Consensus on the Traditional Chinese Medicine Diagnosis and Treatment of Chronic Gastritis(2023)" in formulated by the Spleen and Stomach Disease Branch of the Chinese Association of Chinese Medicine was published in the China Journal of Traditional Chinese Medicineand Pharmacy. Based on the consensus of 2017, the consensus updated and improved the progress of the diagnosis and treatment of chronic gastritis in both Chinese and Western medicine, in order to provided updated and more comprehensive guidance for clinicians to standardize the diagnosis and treatment of chronic gastritis. This article interprets the consensus in order to deepen understanding and improve the clinical diagnosis and treatment level of chronic gastritis.
-
Key words:
- chronic gastritis /
- diagnosis /
- treatment /
- interpretation of expert consensus
-
-
[1] Huang Y, Li H, Long X, et al. Lessons learned from upper gastrointestinal endoscopy in a symptomatic Chinese[J]. Helicobacter, 2021, 26(3): e12803. doi: 10.1111/hel.12803
[2] 房静远, 杜奕奇, 刘文忠, 等. 中国慢性胃炎共识意见(2017年, 上海)[J]. 中华消化杂志, 2017, 37(11): 721-738.
[3] 中华中医药学会脾胃病分会. 慢性胃炎中医诊疗专家共识意见(2017)[J]. 中华中医药杂志, 2017, 32(7): 3060-3064.
[4] 中华中医药学会脾胃病分会. 慢性胃炎中医诊疗专家共识(2023)[J]. 中华中医药杂志, 2023, 38(12): 5904-5911.
[5] Du Y, Bai Y, Xie P, et al. Chronic gastritis in China: a national multi center survey[J/OL]. BMC Gastroenterol, 2014, 14: 21 (2014-02-07)[2023-01-16]. DOI:
10.1186/1471-230X-14-21 .[6] 中华医学会消化病学分会胃肠动力学组. 慢性胃炎患者消化不良症状、胃动力功能及有关因素的多中心调研[J]. 中华消化杂志, 2006, 26(9): 602-605.
[7] 中国中西医结合学会消化系统疾病专业委员会. 慢性萎缩性胃炎中西医结合诊疗共识意见(2017年)[J]. 中国中西医结合消化杂志, 2018, 26(2): 121-131. doi: 10.3969/j.issn.1671-038X.2018.02.03
[8] Arévalo Galvis A, Trespalacios Rangel AA, Ostero Regino W. Personalized therapy for Helicobacter pylori: CYP2C19 genotype effect on first-line triple therapy[J]. Helicobacter, 2019, 24(3): e12574. doi: 10.1111/hel.12574
[9] Kirchheiner J, Glatt S, Fuhr U, et al. Relative potency of proton-pump inhibitors-comparison of effects on intragastric pH[J]. Eur J Clin Pharmacol, 2009, 65(1): 19-31. doi: 10.1007/s00228-008-0576-5
[10] Alhammadi N, Asiri AH, Alshahrani FM, et al. Gastrointestinal Complications Associated With Non-steroidal Anti-inflammatory Drug Use Among Adults: A Retrospective, Single-Center Study[J]. Cureus, 2022, 14(6): e26154.
[11] EI-Zimaity HM, Ramchatesingh J, Saeed MA, et al. Gastric intestinal metaplasia: subtypes and natural history[J]. J Clin Pathol, 2001, 54(9): 679-683. doi: 10.1136/jcp.54.9.679
[12] González CA, Sanz-Anquela JM, Gisbert JP, et al. Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence[J]. Int J Cancer, 2013, 133(5): 1023-1032. doi: 10.1002/ijc.28003
[13] Mera RM, Bravo LE, Camargo MC, et al. Dynamics of helicobacter pylori infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial[J]. Gut, 2018, 67(7): 1239-1246. doi: 10.1136/gutjnl-2016-311685
[14] Shah SC, Gawron AJ, Mustafa RA, et al. Histologic Subtyping of Gastric Intestinal Metaplasia: Overview and Considerations for Clinical Practice[J]. Gastroenterology, 2020, 158(3): 745-750. doi: 10.1053/j.gastro.2019.12.004
[15] Piazuelo MB, Bravo LE, Mera RM, et al. The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions[J]. Gastroenterology, 2021, 160 (4): 1106-1117.e3. doi: 10.1053/j.gastro.2020.11.017
[16] Correa P. Gastric cancer: overview[J]. Gastroenterol Clin North Am, 2013, 42(2): 211-217. doi: 10.1016/j.gtc.2013.01.002
[17] Gupta S, Li D, El Serag HB, et al. AGA Clinical Practice Guidelines on Management of Gastric Intestinal Metaplasia[J]. Gastroenterology, 2020, 158(3): 693-702. doi: 10.1053/j.gastro.2019.12.003
[18] Pimentel-Nunes P, Libanio D, Marcos-Pinto R, et al. Management of epithelial precancerous conditions and lesions in the stomach(MAPS Ⅱ): European Society of Gastrointestinal Endoscopy(ESGE), European Helicobacter and Microbiota Study Group(EHMSG), European Society of Pathology(ESP), and Sociedade Portuguesa de Endoscopia Digestiva(SPED)guideline update 2019[J]. Endoscopy, 2019, 51(4): 365-388. doi: 10.1055/a-0859-1883
[19] Coati I, Fassan M, Farinati F, et al. Autoimmune gastritis: Pathologist's viewpoint[J]. World J Gastroenterol, 2015, 21(42): 12179-12189. doi: 10.3748/wjg.v21.i42.12179
[20] Checchi S, Montanaro A, Pasqui L, et al. Serum ghrelin as a marker of atrophic body gastritis in patients with parietal cell antibodies[J]. J Clin Endocrinol Metab, 2007, 92(11): 4346-4351. doi: 10.1210/jc.2007-0988
[21] 中华医学会消化病学分会, 中华医学会消化病学分会消化系统肿瘤协作组. 中国慢性胃炎诊治指南(2022年, 上海)[J]. 中华消化杂志, 2023, 43(3): 145-175.
[22] Zheng W, Zhang X, Kim JJ, et al. High Accuracy of Convolutional Neural Network for Evaluation of Helicobacter pylori Infection Based on Endoscopic Images: Preliminary Experience[J]. Clin Transl Gastroenterol, 2019, 10(12): e00109. doi: 10.14309/ctg.0000000000000109
[23] Nakashima H, Kawahira H, Kawachi H, et al. Endoscopic three-categorical diagnosis of Helicobacter pylori infection using linked color imaging and deep learning: a single-center prospective study(with video)[J]. Gastric Cancer, 2020, 23(6): 1033-1040. doi: 10.1007/s10120-020-01077-1
[24] Bang CS, Lee JJ, Baik GH. Artificial Intelligence for the Prediction of Helicobacter pylori Infection in Endoscopic Images: Systematic Review and Meta-Analysis of Diagnostic Test Accuracy[J]. J Med Internet Res, 2020, 22(9): e21983. doi: 10.2196/21983
[25] Lin N, Yu T, Zheng W, et al. Simultaneous Recognition of Atrophic Gastritis and Intestinal Metaplasia on White Light Endoscopic Images Based on Convolutional Neural Networks: A Multicenter Study[J]. Clin Transl Gastroenterol, 2021, 12(8): e00385. doi: 10.14309/ctg.0000000000000385
[26] 刘宪华, 侯政昆, 刘凤斌. 慢性胃炎中医证型及其症状条目库的构建和优化[J]. 中医杂志, 2016, 57(17): 1468-1471.
[27] 徐大志, 王艳, 张维, 等. 慢性胃炎常见中医证候及证候要素的文献分析[J]. 湖南中医药大学学报, 2015, 35(7): 54-56.
[28] 黄远程, 黄超原, 梁怀枫, 等. 慢性非萎缩性胃炎与慢性萎缩性胃炎证候、证素分布规律文献研究[J]. 中医杂志, 2019, 60(16): 1417-1422.
[29] 梁敏, 周晓虹. 幽门螺杆菌相关性胃病的中医证型研究概况[J]. 中医研究, 2020, 33(9): 66-70.
[30] 秦珂馨, 于靖文, 王少丽, 等. 基于文献的慢性萎缩性胃炎胃镜像与中医辨证的相关性研究[J]. 云南中医学院学报, 2022, 45(6): 28-34.
[31] 唐伟, 周正光, 王欢欢. 胃脘痛中医辨证与胃镜表现的关联规则分析[J]. 中国中西医结合杂志, 2013, 33(3): 303-306.
[32] 徐进康, 徐宏伟, 陈文奇, 等. 胃病胃镜像与中医辨证的相关性探讨[J]. 南京中医药大学学报, 2009, 25(3): 178-180.
[33] 唐旭东, 马祥雪. 传承董建华"通降论"学术思想, 创建脾胃病辨证新八纲[J]. 中国中西医结合消化杂志, 2018, 26(11): 893-896. doi: 10.3969/j.issn.1671-038X.2018.11.01
[34] 中华中医药学会脾胃病分会, 中华医学会消化病学分会消化肿瘤协作组, 中华医学会消化内镜学分会早癌协作组, 等. 中国整合胃癌前病变临床管理指南[J]. 中国中西医结合消化杂志, 2022, 30(3): 163-183. doi: 10.3969/j.issn.1671-038X.2022.03.01
[35] Plummer M, Franceschi S, Vignat J, et al. Global burden of gastric cancer attributable to Helicobacter pylori[J]. Int J Cancer, 2015, 136(2): 487-490. doi: 10.1002/ijc.28999
[36] Sugano K, Tack J, Kuipers EJ, et al. Kyoto global consensus report on Helicobacter pylori gastritis[J]. Gut, 2015, 64(9): 1353-1367. doi: 10.1136/gutjnl-2015-309252
[37] Evans JA, Chandrasekhara V, Chathadi KV, et al. The role of endoscopy in the management of premalignant and malignant conditions of the stomach[J]. Gastrointest Endosc, 2015, 82(1): 1-8. doi: 10.1016/j.gie.2015.03.1967
[38] 赵婧, 赵泓玮, 宋亚华, 等. 胃内亮蓝嵴和白色不透明物质与胃黏膜肠上皮化生相关性分析[J]. 同济大学学报(医学版), 2020, 41(5): 638-643.
[39] 王立梅, 刘晗. 光学增强内镜(OE)对胃肠上皮化生准确性研究[J]. 中国医疗器械信息, 2022, 28(11): 38-40.
[40] Zhou Y, Li HY, Zhang JJ, et al. Operative link on gastritis assessment stage is an appropriate predictor of early gastric cancer[J]. World J Gastroenterol, 2016, 22(13): 3670-3678. doi: 10.3748/wjg.v22.i13.3670
[41] Rugge M, Genta RM, Fassan M, et al. OLGA Gastritis Staging for the Prediction of Gastric Cancer Risk: A Long-term Follow-up Study of 7436 Patients[J]. Am J Gastroenterol, 2018, 113(11): 1621-1628. doi: 10.1038/s41395-018-0353-8
[42] Rugge M, Meggio A, Pravadelli C, et al. Gatritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients[J]. Gut, 2019, 68(1): 11-17. doi: 10.1136/gutjnl-2017-314600
[43] Isajevs S, Liepniece-Karele I, Janciauskas D, et al. Gastritis staging: interobserver agreement by applying OLGA and OLGIM systems[J]. Virchows Arch, 2014, 464(4): 403-407. doi: 10.1007/s00428-014-1544-3
[44] Lee JWJ, Zhu F, Srivastava S, et al. Severity of gastric intestinal metaplasia predicts the risk of gastric cancer: a prospective multicentre cohort study(GCEP)[J]. Gut, 2022, 71(5): 854-863. doi: 10.1136/gutjnl-2021-324057
[45] 吕东, 孙少鹏, 吕宾. 内镜评估胃癌发生风险的研究现状[J]. 胃肠病学, 2022, 27(12): 759-763.
[46] 国家消化系疾病临床医学研究中心(上海), 国家消化道早癌防治中心联盟(GECA), 中华医学会消化病学分会幽门螺杆菌学组, 等. 中国胃黏膜癌前状态及病变的处理策略专家共识(2020)[J]. 中华消化内镜杂志, 2020, 37(11): 769-780.
[47] Masuyama H, Yoshitake N, Sasai T, et al. Relationship between the degree of endoscopic atrophy of the gastric mucosa and carcinogenic risk[J]. Digestion, 2015, 91(1): 30-36. doi: 10.1159/000368807
[48] 杨振华, 孙波, 黄傲霜, 等. 慢性萎缩性胃炎中医证候的胃镜及病理特征分析研究[J]. 中国中西医结合消化杂志, 2021, 29(1): 58-61. doi: 10.3969/j.issn.1671-038X.2021.01.12
[49] 宋健, 袁敏惠, 刘争辉, 等. 基于血清胃蛋白酶原水平对于胃癌前病变高危证候类型的癌变风险相关性研究[J]. 时珍国医国药, 2020, 31(7): 1658-1660.
[50] 杨洋, 瞿先侯, 杨敏, 等. 慢性萎缩性胃炎患者中医证候分型与癌变风险的相关性[J]. 中医杂志, 2020, 61(4): 319-324.
[51] 王萍, 史彬, 温艳东, 等. 胃癌前病变病证结合风险预测模型的构建研究[J]. 中国中西医结合杂志, 2018, 38(7): 773-778.
[52] 国家药监局药审中心. 国家药监局药审中心关于发布《中药新药用于慢性胃炎的临床疗效评价技术指导原则(试行)》的通告(2022年第47号)[EB/OL]. (2022-12-19)
https://www.cde.org.cn/main/news/viewInfoCommon/ .[53] 中华中医药学会脾胃病分会, 中国医师协会中西医结合医师分会消化病学专业委员会. 胃黏膜定标活检技术临床应用共识(2018)[J]. 中国中西医结合杂志, 2018, 38(12): 1496-1500.
[54] Jackson WF. Long-term Visibility of Endoscopic Tattoos Using Sterile Carbon Suspension in a Pre-filled Syringe: 213[J]. Am J Gastroenterol, 2017, 112: S115-S116.
[55] Arteaga-González I, Martín-Malagón A, Fernández EM, et al. The use of preoperative endoscopic tattooing in laparoscopic colorectal cancer surgery for endoscopically advanced tumors: a prospective comparative clinical study[J]. World J Surg, 2006, 30(4): 605-611. doi: 10.1007/s00268-005-0473-3
[56] 王萍, 尹晓岚, 张北华, 等. 近40年慢性萎缩性胃炎及胃癌前病变中医研究述评[J]. 中医杂志, 2020, 61(22): 1943-1947.
[57] Tang XD, Zhou LY, Zhang ST, et al. Randomized double-blind clinical trial of Moluodan for the treatment of chronic atrophic gastritis with dysplasia[J]. Chin J Integr Med, 2016, 22(1): 9-18. doi: 10.1007/s11655-015-2114-5
[58] Bian Y, Chen X, Cao H, et al. A correlational study of Weifuchun and its clinical effect on intestinal flora in precancerous lesions of gastric cancer[J]. Chin Med, 2021, 16(1): 120. doi: 10.1186/s13020-021-00529-9
-
计量
- 文章访问数: 2023
- PDF下载数: 1272
- 施引文献: 0
下载: